Repository logo

  • Help
  • Log In(current)
    1. Home
    2. NT Health Research
    3. Research and Conference Publications
    4. EMERGE: Early antiMicrobial stEwaRdship for GEneral medicine patients—targeting inpatient intravenous therapy greater than 24 hours
    Details
    Title

    EMERGE: Early antiMicrobial stEwaRdship for GEneral medicine patients—targeting inpatient intravenous therapy greater than 24 hours

    Author(s)
    Khumra, Sharmila
    Thomas, Ashmitha
    Vogrin, Sara
    Batrouney, Adele
    Lowe, Kate
    Camilleri, Shayne
    Jones, Nicholas
    Trubiano, Jason
    Motaganahalli, Satwik
    Reynolds, Gemma
    Abstract
    Objective:
    Early review of intravenous (IV) antimicrobial therapy is central to antimicrobial stewardship (AMS), however scalable models for general medical patients are limited. We evaluated a pharmacist-led digital intervention to optimize IV antimicrobial prescribing.
    Methods:
    A prospective, quasi-experimental before-and-after study was conducted between May 2022 to February 2023 across six general medicine units at a tertiary hospital. AMS recommendations were delivered electronically via Microsoft Teams®. Adult inpatients receiving IV antimicrobials for >24 hours were included, excluding those with COVID-19, under Infectious Diseases consultation or receiving palliative care. The primary outcome was median IV antimicrobial duration. Secondary outcomes included AMS recommendation type, recommendation acceptance, length of stay (LOS), 30-day infection-related readmission, IV therapy recommencement, and inpatient mortality. Antibacterial consumption was analyzed from July 2021 to through December 2024 to evaluate sustained impact.
    Results:
    Among 723 antimicrobial orders (474 treatment episodes in 458 patients), median IV duration was comparable between phases (intensive: 2.75 days; baseline: 3.00 days). LOS was shorter during the intensive phase compared to baseline (5.5 vs 7.6 days; P = .04), particularly in patients without bacteremia. Readmissions and mortality were unchanged. Of 400 AMS recommendations, 67% were IV-to-oral switches; overall acceptance was 78%. Piperacillin-tazobactam use declined, and sustained reductions in aminoglycosides, ampicillin and IV flucloxacillin were observed. A reduction in total antibiotic prescribing (combined IV and oral prescribing) was also observed.
    Conclusions:
    The digital pharmacist-led AMS intervention did not reduce IV duration, likely reflecting strong baseline prescribing, but was associated with shorter LOS and a reduction in total antibacterial use. This program offered a scalable, sustainable alternative to resource-intensive face-to-face models.
    Publication information
    ASHE. 2026; 26(1): e71. doi: 10.1017/ash.2026.10313
    File(s)
    Loading...
    Thumbnail Image
    Download
    Name

    EMERGE.pdf

    Description
    Re-used under a Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/
    Size

    287.42 KB

    Format

    Adobe PDF

    Checksum

    (MD5):047540f9e372715ea3cfad1bd3c258d8

    Date Issued
    2026-03-27
    Type
    Journal Article
    Journal Title
    Antimicrobial stewardship & healthcare epidemiology
    DOI
    10.1017/ash.2026.10313
    Permanent link to this record
    https://hdl.handle.net/10137/15335
    Link to related resource
    Link to article
    Owning collection
    Research and Conference Publications

    NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

    © 2025 Northern Territory Government of Australia